Insights

Niche neurodrug Azevan is actively developing SRX246 for neuropsychiatric symptoms in Huntington's disease, indicating an opportunity to introduce CNS formulation, regulatory strategy support, or CRO partnerships focused on neurodegenerative targets.

Early-stage funding With a modest revenue base and funding of about 2.2 million, there is a clear need for cost-effective development partnerships, grant consulting, and milestone-driven outsourcing to extend runways baring capital.

Small team agility Azevan’s small headcount suggests readiness for streamlined vendor relationships, white-label collaboration, and scalable services from contract research organizations and manufacturing partners to accelerate timeline with minimal overhead.

Digital presence Recent website updates and a technology stack including WordPress, GitHub Pages, and modern web tools imply potential for digital engagement outsourcing, lead gen, and regulatory/clinical trial information dissemination improvements.

Market positioning Operating in the crowded pharmaceutical services landscape with peers of varying scale, Azevan may benefit from competitive benchmarking, partner networks, and pilot programs to validate CSO, CMO, or collaboration opportunities in specialty drug development.

Similar companies to Azevan Pharmaceuticals

Azevan Pharmaceuticals Tech Stack

Azevan Pharmaceuticals uses 8 technology products and services including Varnish, RSS, WordPress, and more. Explore Azevan Pharmaceuticals's tech stack below.

  • Varnish
    Caching
  • RSS
    Content Management System
  • Content Management System
  • Register.com
    Domain Name Services
  • jQuery
    Javascript Libraries
  • GitHub Pages
    Platform As A Service
  • Ruby
    Programming Languages

Azevan Pharmaceuticals's Email Address Formats

Azevan Pharmaceuticals uses at least 0 email formats:
Azevan Pharmaceuticals Email FormatsExamplePercentage

Frequently Asked Questions

What is Azevan Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Azevan Pharmaceuticals's official website is azevan.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Azevan Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2026, Azevan Pharmaceuticals's annual revenue is estimated to be <$1M.

What is Azevan Pharmaceuticals's SIC code and NAICS code?

Minus sign iconPlus sign icon
Azevan Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Azevan Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2026, Azevan Pharmaceuticals has approximately 7 employees across 2 continents, including North America and Asia. Key team members include Chief Executive Officer: N. S. Explore Azevan Pharmaceuticals's employee directory with LeadIQ.

What industry does Azevan Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Azevan Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Azevan Pharmaceuticals use?

Minus sign iconPlus sign icon
Azevan Pharmaceuticals's tech stack includes Varnish, RSS, WordPress, Register.com, Microsoft 365, jQuery, GitHub Pages and Ruby.

How much funding has Azevan Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of October 2026, Azevan Pharmaceuticals has raised $2.2M in funding. The last funding round occurred on Nov 18, 2013 for $2.2M.
Azevan Pharmaceuticals logo

Azevan Pharmaceuticals

Pharmaceutical ManufacturingChina2-10 Employees

Azevan Pharmaceuticals is a small pharmaceutical manufacturing company based in China. The organization operates in drug development and production, reflecting a focus on advancing medicinal candidates through the early stages of the pipeline. With a compact team, the company concentrates its activities within the pharmaceutical sector.

Evidence from 2022 shows Azevan was developing SRX246 as an experimental therapy aimed at neuropsychiatric symptoms associated with Huntington's disease. This indicates a focus on central nervous system conditions and neurodegenerative disease indications within its development efforts. The information presents the company as a player in the early-stage pharmaceutical development space, pursuing a specific therapeutic candidate.

Section iconCompany Overview

Website
azevan.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $2.2M

    Azevan Pharmaceuticals has raised a total of $2.2M of funding over 1 rounds. Their latest funding round was raised on Nov 18, 2013 in the amount of $2.2M as a Venture Round.

  • <$1M

    Azevan Pharmaceuticals's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.